US2011028459A1PendingUtilityA1
Wound Healing
Est. expirySep 20, 2024(expired)· nominal 20-yr term from priority
A61P 41/00A61P 3/10A61P 35/00A61P 9/00A61P 25/00A61P 1/02C09B 5/60A61P 17/00C07D 279/28A61P 19/08A61P 17/02A61P 17/16
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A phenothiazinium compound, compositions and medicaments for use in promoting wound healing and a method for promoting wound healing or cosmetic use by applying or administering a phenothiazinium compound to a wound site or the skin, and optionally exposing the wound site or skin to light.
Claims
exact text as granted — not AI-modified1 .- 9 . (canceled)
10 . A method of cosmetic treatment comprising:
a) applying or administering to an area to be treated an effective amount of a composition comprising a compound of Formula (I)
wherein:
R 1 -R 6 each independently is selected from H, optionally substituted C 1-6 -alkyl, F, Cl, Br and I;
A and B each independently is
R 7 and R 8 each independently is selected from H and optionally substituted C 1-6 -alkyl;
Y is a counteranion; and
p is 1, 2 or 3; and
b) optionally exposing the treated area to light,
wherein said cosmetic treatment is selected from skin rejuvenation, skin thickening, reduction of scar formation and birth mark removal.
11 . The method according to claim 10 , wherein said cosmetic treatment is skin rejuvenation.
12 . The method according to claim 10 , wherein said cosmetic treatment is skin thickening.
13 . The method according to claim 10 , wherein said cosmetic treatment is reduction of scar formation.
14 . The method according to claim 10 , wherein said cosmetic treatment is birth mark removal.
15 . The method according to claim 10 , wherein said composition further comprises a pharmaceutically acceptable diluent or excipient.
16 . The method according to claim 10 , wherein R 7 and R 8 are independently selected from optionally-substituted C 3-6 alkyl.
17 . The method according to claim 10 , wherein Y is a counterion selected from F − , Br 5 − , Cl − , I − , NO 3 − , SCN − , ClO 3 − , ClO 4 − , IO 3 − , BF 4 − , HSO 4 − , H 2 − PO 4 − , CH 3 − SO 4 − , N 3 , SO 4 2− , HPO 4 2− , PO 4 3− , acetate, lactate, citrate, tartrate, glycolate, glycerate, glutamate, β-hydroxyglutamate, glucouronate, gluconate, malate and aspartate.
18 . The method according to claim 10 , wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 each represents H, and R 7 and R 8 represent butyl.
19 . A method of cosmetic treatment comprising:
a) applying or administering to an area to be treated an effective amount of a composition comprising a compound of Formula (1)
wherein:
R 1 -R 6 each independently is selected from H, optionally substituted C 1-6 -alkyl, F, Cl, Br and I;
A and B each independently is
R 7 and R 8 each independently is selected from optionally substituted C 3-6 -alkyl;
Y is a counteranion; and
p is 1, 2 or 3; and
b) optionally exposing the treated area to light,
wherein said cosmetic treatment is selected from skin rejuvenation, skin thickening, reduction of scar formation and birth mark removal.Join the waitlist — get patent alerts
Track US2011028459A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.